588-36-3 Usage
Description
(4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-YL)METHANOL is a white crystalline powder that serves as an intermediate in the synthesis of various compounds, including Thiamine (T344185), pyridopyrimidines, and naphthyridines. These synthesized compounds have potential applications in the treatment of cancer and other diseases.
Uses
Used in Pharmaceutical Industry:
(4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-YL)METHANOL is used as an intermediate for the synthesis of Thiamine (T344185), which is essential for various biological processes and has applications in the pharmaceutical industry.
Used in Cancer Treatment:
(4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-YL)METHANOL is used in the preparation of pyridopyrimidines and naphthyridines, which are inhibitors of Akt kinase. These compounds have potential applications in the treatment of cancer, as they can help regulate cellular processes and inhibit tumor growth.
Used in Tumor Antagonist Research:
(4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-YL)METHANOL has been identified as a tumor antagonist in mice, indicating its potential use in the development of new cancer therapies and treatments.
Chemical Properties:
(4-AMINO-2-(METHYLTHIO)PYRIMIDIN-5-YL)METHANOL is a white crystalline powder, which is a characteristic of its chemical structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 588-36-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,8 and 8 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 588-36:
(5*5)+(4*8)+(3*8)+(2*3)+(1*6)=93
93 % 10 = 3
So 588-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H9N3OS/c1-11-6-8-2-4(3-10)5(7)9-6/h2,10H,3H2,1H3,(H2,7,8,9)
588-36-3Relevant articles and documents
-
Blank,Caldwell
, p. 1137 (1959)
-
Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
Nikhar, Sameer,Siokas, Ioannis,Schlicher, Lisa,Lee, Seungheon,Gyrd-Hansen, Mads,Degterev, Alexei,Cuny, Gregory D.
, (2021/02/22)
Receptor interacting protein kinase-2 (RIPK2) is an enzyme involved in the transduction of pro-inflammatory nucleotide-binding oligomerization domain (NOD) cell signaling, a pathway implicated in numerous chronic inflammatory conditions. Herein, a pyrido[
Pyrido[2,3-d]pyrimidin-7(8H)-one derivatives and Composition for skin whitening and Pharmaceutical composition for use in preventing or treating disorders of Melanin Hyperpigmentation containing the same as an active ingredient
-
, (2020/11/03)
The present invention relates to a pyrido[2,3-d]pyrimidin-7(8H)-one derivative, and to a composition for skin whitening comprising the same as an active ingredient. Since the derivative exhibits an effect of inhibiting the production of melanin even when
PROTEIN KINASE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DISEASES AND CONDITIONS
-
, (2020/11/30)
Identified compounds demonstrate protein kinase inhibitory activity. More specifically, the compounds are demonstrated to inhibit receptor interacting kinase 2 (RIPK2) and/or Activin-like kinase 2 (ALK2) and/or receptor interacting kinase 3 (RIPK3). Compounds that are either dual RIPK2/ALK2 inhibitors or that preferentially inhibit RIPK2 or ALK2 or RIPK3 could provide therapeutic benefit. Compounds that function as RIPK3 inhibitors provide therapeutic benefit in the treatment of inflammatory and degenerative conditions.